Exxon Mobil’s profit dropped in the second quarter to the lowest level in four years as oil prices declined amid an increase ...

Regeneron Pharmaceuticals (NASDAQ:REGN) on Friday topped Street forecasts with its Q2 financials, thanks mainly to U.S. sales ...

Amazon's stock sank on Thursday afternoon, weighed down by mixed guidance and AI competition, though the company beat Q2 ...

Data from Square shows that the average tip on food and beverage transactions has dipped, though drink purchases at bars ...

Installations expected to reach 40,000 homes across North America; company advances toward cash flow positivity in 2025 ...

ClearBridge Portfolios stay balanced amid market highs and AI buzz. See how smart stock picks shaped performance.

Indonesia's economy likely grew at its slowest pace in nearly four years last quarter as weak household spending weighed on ...

Roku’s Platform segment, which includes ad sales, content sales and subscription-revenue sharing, grew sales 18% to $976 ...

Palantir is scheduled to report second-quarter earnings in the next week, and expectations are sky high. Is now a good time ...

Key Points Merit Medical Systems (NASDAQ:MMSI) reported GAAP revenue and non-GAAP earnings per share well above analyst estimates for Q2 2025, with notable strength across all operating segments.

Australia's final demand Producer Price Index increased by 0.7% quarter-on-quarter in Q2 2025, missing market estimates of ...